-
1.
公开(公告)号:US20240294950A1
公开(公告)日:2024-09-05
申请号:US18390570
申请日:2023-12-20
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Stefan Andrae
IPC: C12P5/02 , C12N1/14 , C12N1/20 , C12N15/70 , C12N15/81 , C12P7/02 , C12P7/04 , C12P7/18 , C12P7/40 , C12P7/42 , C12P7/44 , C12P13/00 , C12P17/10
CPC classification number: C12P5/026 , C12N1/14 , C12N1/20 , C12N15/70 , C12N15/81 , C12P7/02 , C12P7/04 , C12P7/18 , C12P7/40 , C12P7/42 , C12P7/44 , C12P13/001 , C12P13/005 , C12P17/10 , Y02E50/30
Abstract: The invention provides non-naturally occurring microbial organisms containing enzymatic pathways and/or metabolic modifications for enhancing carbon flux through acetyl-CoA. In some embodiments, the microbial organisms of the invention having such pathways also include pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation. The enhanced carbon flux through acetyl-CoA, in combination with pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation can, in some embodiments, be used for production of a bioderived compound. Accordingly, in some embodiments, the microbial organisms of the invention can include a pathway capable of producing a bioderived compound of the invention. The invention still further provides a bioderived compound produced by a microbial organism of the invention, culture medium having the bioderived compound of the invention, compositions having the bioderived compound of the invention, a biobased product comprising the bioderived compound of the invention, and a process for producing a bioderived compound of the invention.
-
公开(公告)号:US20240124904A1
公开(公告)日:2024-04-18
申请号:US18453987
申请日:2023-08-22
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Stephen J. Van Dien , Priti Pharkya , Tae Hoon Yang , Jungik Choi
IPC: C12P7/18 , C07K14/245 , C12N1/20 , C12N9/00 , C12N9/02 , C12N9/12 , C12N9/16 , C12N9/52 , C12N9/88 , C12N15/52 , C12P7/42
CPC classification number: C12P7/18 , C07K14/245 , C12N1/20 , C12N9/0036 , C12N9/0057 , C12N9/1205 , C12N9/16 , C12N9/52 , C12N9/88 , C12N9/93 , C12N15/52 , C12P7/42 , C12Y106/01002 , C12Y110/03 , C12Y207/0104 , C12Y301/00 , C12Y301/02 , C12Y301/02002 , C12Y304/21092 , C12Y401/01031 , C12Y401/01032
Abstract: −The invention is directed to a non-naturally occurring microbial organism comprising a first attenuation of a succinyl-CoA synthetase or transferase and at least a second attenuation of a succinyl-CoA converting enzyme or a gene encoding a succinate producing enzyme within a multi-step pathway having a net conversion of succinyl-CoA to succinate.
-
公开(公告)号:US11708592B2
公开(公告)日:2023-07-25
申请号:US17120005
申请日:2020-12-11
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Priti Pharkya , Mark J. Burk
IPC: C12P17/08 , C12N15/70 , C08G63/08 , C07D313/04 , C12N15/63 , C12P17/02 , C08G18/42 , C12N5/00 , C12N15/52
CPC classification number: C12P17/08 , C07D313/04 , C08G18/4277 , C08G63/08 , C12N5/0018 , C12N15/52 , C12N15/63 , C12N15/70 , C12P17/02
Abstract: The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. The invention additionally provides methods of using such microbial organisms to produce caprolactone by culturing a non-naturally occurring microbial organism containing caprolactone pathways as described herein under conditions and for a sufficient period of time to produce caprolactone.
-
4.
公开(公告)号:US20230065295A1
公开(公告)日:2023-03-02
申请号:US17369871
申请日:2021-07-07
Applicant: Genomatica, Inc.
Inventor: Priti Pharkya , Anthony P. Burgard , Stephen J. Van Dien , Robin E. Osterhout , Mark J. Burk , John D. Trawick , Michael P. Kuchinskas , Brian Steer
IPC: C12N1/20 , C12P7/18 , C12N9/18 , C12N15/52 , C12P7/42 , C12N1/14 , C12N1/16 , C12N15/63 , C07C31/20 , C07C59/01 , C08G18/28 , C08G18/32 , C08G63/06 , C08G63/16 , C08G63/181 , C08G69/02
Abstract: The invention provides non-naturally occurring microbial organisms having a 4-hydroxybutyrate pathway and being capable of producing 4-hydroxybutyrate, wherein the microbial organism comprises one or more genetic modifications. The invention additionally provides methods of producing 4-hydroxybutyrate or related products using the microbial organisms.
-
公开(公告)号:US11525149B2
公开(公告)日:2022-12-13
申请号:US15600479
申请日:2017-05-19
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Priti Pharkya
Abstract: A non-naturally occurring eukaryotic or prokaryotic organism includes one or more gene disruptions occurring in genes encoding enzymes imparting increased fumarate, malate or acrylate production in the organism when the gene disruption reduces an activity of the enzyme. The one or more gene disruptions confers increased production of acrylate onto the organism. Organisms that produce acrylate have an acrylate pathway that at least one exogenous nucleic acid encoding an acrylate pathway enzyme expressed in a sufficient amount to produce acrylate, the acrylate pathway comprising a decarboxylase. Methods of producing fumarate, malate or acrylate include culturing these organisms.
-
公开(公告)号:US11371063B2
公开(公告)日:2022-06-28
申请号:US16664549
申请日:2019-10-25
Applicant: Genomatica, Inc.
Inventor: Priti Pharkya , Anthony P. Burgard , Mark J. Burk
IPC: C12P5/02 , C12N15/52 , C12P3/00 , C12P7/40 , C01B3/00 , C08F36/06 , C08F36/14 , C12N9/04 , C12N9/02 , C12N9/10 , C12N9/12
Abstract: The invention provides non-naturally occurring microbial organisms containing butadiene or 2,4-pentadienoate pathways comprising at least one exogenous nucleic acid encoding a butadiene or 2,4-pentadienoate pathway enzyme expressed in a sufficient amount to produce butadiene or 2,4-pentadienoate. The organism can further contain a hydrogen synthesis pathway. The invention additionally provides methods of using such microbial organisms to produce butadiene or 2,4-pentadienoate by culturing a non-naturally occurring microbial organism containing butadiene or 2,4-pentadienoate pathways as described herein under conditions and for a sufficient period of time to produce butadiene or 2,4-pentadienoate. Hydrogen can be produced together with the production of butadiene or 2,4-pentadienoate.
-
公开(公告)号:US11293026B2
公开(公告)日:2022-04-05
申请号:US16550010
申请日:2019-08-23
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Priti Pharkya , Robin E. Osterhout
IPC: C12N1/21 , C12P7/44 , C12N9/04 , C12N9/12 , C12N9/10 , C12N9/88 , C12N9/02 , C12N9/16 , C12N15/52 , C12P13/00 , C12P13/02 , C12P17/10 , C12N9/80 , C12P7/46 , C12P7/62
Abstract: The invention provides a non-naturally occurring microbial organism having an adipate, 6-aminocaproic acid or caprolactam pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective adipate, 6-aminocaproic acid or caprolactam pathway. The invention additionally provides a method for producing adipate, 6-aminocaproic acid or caprolactam. The method can include culturing an adipate, 6-aminocaproic acid or caprolactam producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an adipate, 6-aminocaproic acid or caprolactam pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce adipate, 6-aminocaproic acid or caprolactam.
-
公开(公告)号:US11180780B2
公开(公告)日:2021-11-23
申请号:US15616841
申请日:2017-06-07
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Mark J. Burk , Robin E. Osterhout , Priti Pharkya
IPC: C12N9/88 , C12N9/90 , C12P7/16 , C12N15/00 , C12P7/18 , C12N15/52 , C12N9/04 , C07C29/80 , C12N9/02 , C12N9/10
Abstract: A non-naturally occurring microbial organism includes a microbial organism having a 1,3-butanediol (1,3-BDO) pathway having at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. The pathway includes an enzyme selected from a 2-amino-4-ketopentanoate (AKP) thiolase, an AKP dehydrogenase, a 2-amino-4-hydroxypentanoate aminotransferase, a 2-amino-4-hydroxypentanoate oxidoreductase (deaminating), a 2-oxo-4-hydroxypentanoate decarboxylase, a 3-hydroxybutyraldehyde reductase, an AKP aminotransferase, an AKP oxidoreductase (deaminating), a 2,4-dioxopentanoate decarboxylase, a 3-oxobutyraldehyde reductase (ketone reducing), a 3-oxobutyraldehyde reductase (aldehyde reducing), a 4-hydroxy-2-butanone reductase, an AKP decarboxylase, a 4-aminobutan-2-one aminotransferase, a 4-aminobutan-2-one oxidoreductase (deaminating), a 4-aminobutan-2-one ammonia-lyase, a butenone hydratase, an AKP ammonia-lyase, an acetylacrylate decarboxylase, an acetoacetyl-CoA reductase (CoA-dependent, aldehyde forming), an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming), an acetoacetyl-CoA reductase (ketone reducing), a 3-hydroxybutyryl-CoA reductase (aldehyde forming), a 3-hydroxybutyryl-CoA reductase (alcohol forming), a 4-hydroxybutyryl-CoA dehydratase, and a crotonase. A method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO.
-
9.
公开(公告)号:US20210332393A1
公开(公告)日:2021-10-28
申请号:US17064404
申请日:2020-10-06
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Stefan Andrae
IPC: C12P5/02 , C12P7/18 , C12N1/14 , C12N1/20 , C12P7/42 , C12P7/02 , C12P7/40 , C12N15/70 , C12N15/81 , C12P7/04 , C12P7/44 , C12P13/00 , C12P17/10
Abstract: The invention provides non-naturally occurring microbial organisms containing enzymatic pathways and/or metabolic modifications for enhancing carbon flux through acetyl-CoA. In some embodiments, the microbial organisms of the invention having such pathways also include pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation. The enhanced carbon flux through acetyl-CoA, in combination with pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation can, in some embodiments, be used for production of a bioderived compound. Accordingly, in some embodiments, the microbial organisms of the invention can include a pathway capable of producing a bioderived compound of the invention. The invention still further provides a bioderived compound produced by a microbial organism of the invention, culture medium having the bioderived compound of the invention, compositions having the bioderived compound of the invention, a biobased product comprising the bioderived compound of the invention, and a process for producing a bioderived compound of the invention.
-
公开(公告)号:US20210147881A1
公开(公告)日:2021-05-20
申请号:US16912409
申请日:2020-06-25
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Jun Sun , Robin E. Osterhout , Priti Pharkya
Abstract: The invention provides non-naturally occurring microbial organisms having a butadiene pathway. The invention additionally provides methods of using such organisms to produce butadiene.
-
-
-
-
-
-
-
-
-